Cite
HARVARD Citation
Hanna, C. et al. (2020). Pharmacokinetics, safety, and tolerability of olaparib and temozolomide for recurrent glioblastoma: results of the phase I OPARATIC trial. Neuro-oncology. 22 (12), pp. 1840-1850. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hanna, C. et al. (2020). Pharmacokinetics, safety, and tolerability of olaparib and temozolomide for recurrent glioblastoma: results of the phase I OPARATIC trial. Neuro-oncology. 22 (12), pp. 1840-1850. [Online].